Cointime

Nanoscope Therapeutics

company

About

Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight.

  • 1 - 10

Highlights

Total Funding Amount
$1.50M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$1.50M
Industries
Biotechnology,Health Care,Therapeutics
Founded date
Jan 1, 2017
Number Of Employee
1 - 10
Operating Status
Active

Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists.

They utilize ambient light-sensitive molecules to re-sensitize the retina toward a low light level. Its light-assisted gene therapy is highly targeted to geographic atrophies without perturbing the intact retina circuitry.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$1.50M
Nanoscope Therapeutics has raised a total of $1.50M in funding over 2 rounds. Their latest funding was raised on Sep 14, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 14, 2021 Grant $1.50M 1 National Institutes of Health (NIH) — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Nanoscope Therapeutics is funded by 1 investors. National Institutes of Health (NIH) are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health (NIH) Yes Grant
Cointime
İçerikler
Şirket.